Albrecht, K.; Lotz, J.; Frommer, L. et al.
A rapid point-of-care assay accurately measures vitamin DJOURNAL OF ENDOCRINOLOGICAL INVESTIGATION. Bd. 44. H. 11. 2021 S. 2485-2492
Eslam, Mohammed; Wong, Grace Lai-Hung; Hashem, Ahmed M. et al.
A Sequential Algorithm Combining ADAPT and Liver Stiffness Can Stage Metabolic-Associated Fatty Liver Disease in Hospital-Based and Primary Care PatientsAMERICAN JOURNAL OF GASTROENTEROLOGY. Bd. 116. H. 5. 2021 S. 984-993
Triantafyllias, Konstantinos; Heller, Caroline; de Blasi, Michele et al.
A Sex Difference in HandScan Scores in Rheumatoid Arthritis Patients and Controls? An Ongoing Analysis of the Sex Difference and Other Potential Confounders ReplyJOURNAL OF RHEUMATOLOGY. Bd. 48. H. 6. 2021 S. 951-951
Castven, Darko; Czauderna, Carolin; Becker, Diana et al.
Acquired Resistance to Antiangiogenic Therapies in Hepatocellular Carcinoma Is Mediated by Yes-Associated Protein 1 Activation and Transient Expansion of Stem-Like Cancer CellsHEPATOLOGY COMMUNICATIONS. Bd. 6. H. 5. 2021 S. 1140-1156
Zander, T.; Kelly, R. J.; Ajani, J. A. et al.
Adjuvant nivolumab (NIVO) in resected esophageal or gastroesophageal junction cancer (EC/GEJC) following neoadjuvant chemoradiotherapy (CRT): expanded efficacy and safety analyses from CheckMate 577ONCOLOGY RESEARCH AND TREATMENT. Bd. 44. 2021 S. 80-81
Kelly, Ronan Joseph; Ajani, Jaffer A.; Kuzdzal, Jaroslaw et al.
Adjuvant nivolumab (NIVO) in resected esophageal or gastroesophageal junction cancer (EC/GEJC) following neoadjuvant chemoradiotherapy (CRT): Expanded efficacy and safety analyses from CheckMate 577.JOURNAL OF CLINICAL ONCOLOGY. Bd. 39. H. 15. 2021
Kelly, Ronan J.; Ajani, Jaffer A.; Kuzdzal, Jaroslaw et al.
Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction CancerNEW ENGLAND JOURNAL OF MEDICINE. Bd. 384. H. 13. 2021 S. 1191-1203
Moehler, M.; Ajani, J. A.; Kuzdzal, J. et al.
Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer (EC/GEJC) following neoadjuvant chemoradiotherapy (CRT): 14-month follow-up of CheckMate 577ANNALS OF ONCOLOGY. Bd. 32. 2021 S. S1045-S1046
Kelly, R. J.; Ajani, J.; Kuzdzal, J. et al.
Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer Following Neoadjuvant Chemoradiation Therapy: First Results of the CheckMate 577 StudyANNALS OF SURGICAL ONCOLOGY. Bd. 28. H. SUPPL 1. 2021 S. S41-S42
Hagstrom, Hannes; Adams, Leon A.; Allen, Alina M. et al.
Administrative Coding in Electronic Health Care Record-Based Research of NAFLD: An Expert Panel Consensus StatementHEPATOLOGY. Bd. 74. H. 1. 2021 S. 474-482